Search alternatives:
significantly extended » significantly enhanced (Expand Search), significantly altered (Expand Search), significantly decreased (Expand Search)
significantly extended » significantly enhanced (Expand Search), significantly altered (Expand Search), significantly decreased (Expand Search)
-
1
-
2
-
3
Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity.
Published 2024“…(<b>C</b>) Pyr at 500 μM significantly decreased axon length ratio over time and was significantly lower than PBS control by day 3. …”
-
4
Viloxazine Extended-Release: A Review of in Attention-Deficit/Hyperactivity Disorder in Adults
Published 2025“…</p><p><br></p><p dir="ltr"><b>Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability</b> not applicable</p><p><br></p><p dir="ltr">Additional information about this Adis Drug Review can be found <a href="https://www.springer.com/gp/adis/products-services/adis-journals-newsletters/adis-drug-reviews" target="_blank">here</a></p><p><br></p><p dir="ltr"><b>Abstract</b></p><p dir="ltr">An extended-release once-daily oral capsule formulation of viloxazine (viloxazine ER; Qelbree®), a norepinephrine reuptake inhibitor and serotonin receptor modulator, has been approved in the USA for the treatment of attention-deficit/hyperactivity disorder (ADHD) in paediatric patients and adults. …”
-
5
-
6
Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use
Published 2024“…</p> <p><br></p> <p> </p> <p><strong>Abstract </strong>Sodium oxybate extended-release suspension (LUMRYZ™; hereafter referred to as sodium oxybate ER) represents a promising novel option for the treatment of narcolepsy. …”
-
7
-
8
-
9
-
10
Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review
Published 2024“…Among other barriers, daily dosing requirements hinder treatment continuity post-release. Extended-release buprenorphine (XR-BUP) may therefore be beneficial. …”
-
11
Effect of extended-release buprenorphine (1 mg/kg SC) on tactile hypersensitivity in a rat model of inflammation.
Published 2024“…<p>The mechanical nociceptive threshold is transiently changed by extended-release buprenorphine. Initial hypersensitivity tested at time point 0 was compared to time points following administration of extended-release buprenorphine (Bupe ER). …”
-
12
-
13
-
14
-
15
-
16
DataSheet1_Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials.zip
Published 2022“…<p>Purpose: A novel once-daily divalproex-extended release (ER) dose formulation has been developed; this formulation prolongs the therapeutic serum levels of the drug, compared with the twice-daily conventional divalproex-delayed release (DR) formulation. …”
-
17
-
18
-
19
-
20
Impact of the virtual learning environment on the number of correct answers.
Published 2022Subjects: